Wednesday, February 5, 2025
spot_img

January 2025 – voting rights

PRESS RELEASE
Paris, February 5, 2025

Information on the total number of voting rights
and shares forming the share capital
(Article L.233-8 II of the French Commercial Code and
Article 223-16 of the General Regulation of the French Financial Markets Authority)

Date

Issued capital

Par value

Total number of shares

Total number of voting rights
Theoretical* Exercisable**

January 31, 2025

€ 244,633,504 € 1 244,633,504 274,030,114 272,343,236

*In accordance with Article 223-11 of the General Regulation of the French Financial Markets Authority, the total number of theoretical voting rights is calculated on the basis of all shares to which voting rights are attached, including shares deprived of voting rights.
** The total number of exercisable voting rights is calculated without taking into account shares deprived of voting rights.

About Valeo

As a technology company and partner to all automakers and new mobility players, Valeo is innovating to make mobility cleaner, safer and smarter. Valeo enjoys technological and industrial leadership in electrification, driving assistance systems, reinvention of the interior experience and lighting everywhere. These four areas, vital to the transformation of mobility, are the Group’s growth drivers.

Valeo in figures: 22 billion euros in sales in 2023 | 109,600 employees, 28 countries, 159 plants, 64 research and development centers, 19 distribution platforms at June 30, 2024.

Valeo is listed on the Paris Stock Exchange.

Attachment

  • PR_Valeo_voting rights_January 2025

Powered by SlickText.com

Hot this week

Novo Nordisk files annual report with the SEC

Bagsværd, Denmark, 5 February 2025 – Novo Nordisk A/S...

Alliance Witan PLC – Net Asset Value

ALLIANCE WITAN PLC                 At the close of business on Tuesday...

Stallion Uranium Commences Ground Electromagnetic Survey on High Priority Drill Targets

VANCOUVER, British Columbia, Feb. 05, 2025 (GLOBE...

Hydreight Technologies Expands Telehealth Offerings with Launch of NAD+ Therapy on VSDHOne Platform

New NAD+ Patch, Injection, and Nasal Spray Now Available...

Topics

Novo Nordisk files annual report with the SEC

Bagsværd, Denmark, 5 February 2025 – Novo Nordisk A/S...

Alliance Witan PLC – Net Asset Value

ALLIANCE WITAN PLC                 At the close of business on Tuesday...

FirstService Reports Fourth Quarter and Full Year Results

Strong Revenue Growth Drives ProfitabilityOperating highlights:   Three months ended Year...
spot_img

Related Articles

Popular Categories

spot_img